A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.

Illumina will offer its DRAGEN analysis software on Nvidia’s accelerated computing platforms through the next-gen sequencing ...

Authenticated data presented in the Animal Model market report is based on findings of extensive primary and secondary research.

Richard Hogg, chief technical officer of UK-based company III-V Epi, is advocating using GaAs epitaxial regrowth for many ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a ...

NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength ...

Spike. © Emphase/EPFL The use of generative artificial intelligence in protein design stands to revolutionize new drug ...

Gen AI and other technologies are set to transform the healthcare realm. The collaboration between engineers, clinicians, and Indo-US firms will be critical to ensuring quality of care, diagnostic ...

A loss-of-function mutation to the PTPN2 gene, commonly associated with autoimmune diseases, can make cells more susceptible ...

Surge in chronic disease triggers a search for tools to improve treatment access for millions of people at risk ...

AI development powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference in San Francisco by announcing new ...